Live Marvell Technology Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow BAXTER INTERNATIONAL INC

Get SEC filing alerts via email and in your feed for BAXTER INTERNATIONAL INC

BAX

BAXTER INTERNATIONAL INC

About BAXTER INTERNATIONAL INC

Baxter International Inc. develops and manufactures a broad range of essential healthcare products, including sterile IV solutions, infusion systems, parenteral nutrition, surgical hemostats, smart bed systems, patient monitoring technologies, respiratory devices, and specialty pharmaceuticals. Serving hospitals, clinics, and home care globally, Baxter’s diversified portfolio and integrated supply chain support cost-effective, innovative healthcare solutions across developed and emerging markets. Its business model emphasizes product innovation, operational efficiency, and global distribution.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from BAXTER INTERNATIONAL INC

1
1
BAXTER INTERNATIONAL INC Baxter International Reports $15 Million Net Loss in Q1 2026 Amid Restructuring Efforts

Via official filing (AI summary) | about 1 month ago | 0 comments

2
1
BAXTER INTERNATIONAL INC Baxter International Reports 6% Sales Increase but $957 Million Net Loss for Fiscal Year 2025

Via official filing (AI summary) | 4 months ago | 0 comments

3
1
BAXTER INTERNATIONAL INC Baxter International Reports Q3 2025 Net Loss of $46 Million Amid Sales Growth

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
BAXTER INTERNATIONAL INC Baxter International Reports Q2 2025 Net Income of $91 Million, Sales Up 4%

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
BAXTER INTERNATIONAL INC Baxter International Reports $126 Million Net Income and $2.625 Billion in Sales for Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
BAXTER INTERNATIONAL INC Baxter International Reports Mixed Q3 2024 Results Amid Strategic Developments and Operational Disruptions

Via official filing (AI summary) | over 1 year ago | 0 comments